Current Activities and Meetings...

New Activities
Poster Awards- The ISF will be providing awards for the best poster on Sepsis at various International Conferences. More detail will be made available on this site in the future.

Sepsis 2009

November 2009, Amsterdam, The Netherlands

ISF co-session with ESICM 2009

Vienna Austria  11-14 October

Chairs: JF Dhainaut & K Reinhart

1) Combination antibiotic therapy is indicated in sever bacteremic pneumococcal pneumonia. 

Pro: John Marshall  

Con: Jean Carlet

2) Vasopressin remains an important therapy for the management of septic shock

Pro: Jean-Louis Vincent

Con: Simon Finfer

3) PCT measurement should now be the standard of care in patients with suspected infection

Pro: Konrad Reinhart

Con: Derek Angus

ISF Joint Session ECCMID 2009

Tuesday 19 May 2009, Helsinki, Finland.  Beyond Antibiotics: The Biologic Basis and Clinical Utility of Adjuvant Therapy for Severe Pneumonia.

Presentation by Dr. Landelle for best Sepsis Abstract at ECCMID

The host response in severe pneumonia: Insights from pre-clinical studies - Tom van der Poll, Amsterdam, Netherlands

Microbial virulance factors - Steven Opal, Providence Rhode Island

Biomarkers and severity stratification - Konrad Reinhart, Jena Germany

Adjuvant therapy: Results from clinical trials - John Marshall, Toronto, Canada

ISF 8th Annual Colloquium on Divergences and Convergences of the Septic Phenotype. 

May 4-5, 2009.  Pheasant Run, St Charles, IL

ISICEM 2009

ISF is endorsing the International Symposium for Intensive Care and Emergency Medicine (ISICEM) Brussels, March 2009

Surviving Sepsis Campaign (SSC)
The ISF has collaborated with the European Society of Intensive Care Medicine (ESICM) and the Society of Critical Care Medicine (SCCM) on the Surviving Sepsis Campaign (SSC). The mission of the Surviving Sepsis Campaign is to raise awareness of Sepsis and to reduce the mortality of Sepsis.  Click here to go the SSC website.

InFACT

A number of investigator-led research consortia met in Granada Spain in November 2008 to explore ways they might better collaborate to advance investigator-led clinical research in critical care.  Over the past two decades, a number of investigator-led research consortia have emerged around the world, and have assumed a pre-eminent role in shaping the landscape of critical care research.  The meeting was an exploratory one to identify areas  where we might develop ongoing collaborative activities.  Following the meeting a short document will be developed that will outline the plan for InFACT and plans for a future meeting.

This page last updated 03/16/2009